Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New rectal cancer device could spare elderly patients from surgery

NCT ID NCT04336202

First seen Apr 29, 2026 · Last updated Jun 23, 2026 · Updated 9 times

Summary

This pilot study tests a new rectal applicator for brachytherapy in 45 elderly patients with inoperable rectal cancer. Participants receive external beam radiotherapy followed by three brachytherapy treatments using the new device. The study aims to see if the device is feasible, safe, and effective at controlling the tumor, while monitoring for severe side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECTAL CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Jewish General Hospital

    Montreal, Quebec, H3T 1E2, Canada

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

External beam radiotherapy and endorectal brachytherapy using a new rectal applicator

What this could lead to

If successful, this could offer a safer, more effective radiation treatment option for elderly patients with inoperable rectal cancer, potentially improving quality of life and tumor control.

What could go wrong

This is a small pilot study with only 45 participants and is currently suspended. The new device may cause severe side effects like rectal bleeding or diarrhea, and the trial has strict stopping rules for toxicity.

Conditions

The condition(s) this trial relates to.

rectal neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.